Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 28, 2022

Details for New Drug Application (NDA): 020857

✉ Email this page to a colleague

« Back to Dashboard

NDA 020857 describes COMBIVIR, which is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the COMBIVIR profile page.

The generic ingredient in COMBIVIR is lamivudine; zidovudine. There are twenty-nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.
Summary for 020857
Applicant:Viiv Hlthcare
Ingredient:lamivudine; zidovudine
Pharmacology for NDA: 020857
Suppliers and Packaging for NDA: 020857
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857 NDA ViiV Healthcare Company 49702-202 49702-202-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG;300MG
Approval Date:Sep 26, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020857

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.